Signal2026-07-13
ClinicalTrials.gov

[PHASE4] AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes

Part of

Metabolic Interventions And Cardiometabolic Outcomes

Open primary sourceSee the whole picture